 AMAG Pharmaceuticals NASDAQ:AMAG had its target price reduced by HC Wainwright from 12.00 to 9.00 in a research report report published on Friday morning, The Fly reports. HC Wainwright currently has a buy rating on the specialty pharmaceutical companys stock. Other equities analysts have also issued reports about the stock. Barclays reiterated a buy rating ... 